{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:38:07Z","timestamp":1784036287763,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA284531"],"award-info":[{"award-number":["R01CA284531"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA249867"],"award-info":[{"award-number":["R01CA249867"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA249867"],"award-info":[{"award-number":["R01CA249867"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210027"],"award-info":[{"award-number":["RP210027"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003287","name":"Rally Foundation","doi-asserted-by":"publisher","award":["23CDNO5"],"award-info":[{"award-number":["23CDNO5"]}],"id":[{"id":"10.13039\/100003287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41375-025-02602-w","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:07:32Z","timestamp":1744358852000},"page":"1516-1519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["All genetic subtypes of B-cell acute lymphoblastic leukemia exhibit increased incidence rates in children with Down syndrome"],"prefix":"10.1038","volume":"39","author":[{"given":"Ching-Ju","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-9562","authenticated-orcid":false,"given":"Jeremy M.","family":"Schraw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania A.","family":"Desrosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda E.","family":"Janitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell S.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Nestoridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy N.","family":"Nembhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0077-6023","authenticated-orcid":false,"given":"Jason L.","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Shumate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Paul","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa M.","family":"Yazdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8379-6088","authenticated-orcid":false,"given":"Michael E.","family":"Scheurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4081-8195","authenticated-orcid":false,"given":"Karen R.","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0978-5863","authenticated-orcid":false,"given":"Philip J.","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"2602_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/jmg.33.5.387","volume":"33","author":"D Mutton","year":"1996","unstructured":"Mutton D, Alberman E, Hook EB. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. J Med Genet. 1996;33:387\u201394.","journal-title":"J Med Genet"},{"key":"2602_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","volume":"355","author":"H Hasle","year":"2000","unstructured":"Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome. Lancet Lond Engl. 2000;355:165\u20139.","journal-title":"Lancet Lond Engl"},{"key":"2602_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/jamaoncol.2019.1215","volume":"5","author":"PJ Lupo","year":"2019","unstructured":"Lupo PJ, Schraw JM, Desrosiers TA, Nembhard WN, Langlois PH, Canfield MA, et al. Association between birth defects and cancer risk among children and adolescents in a population-based assessment of 10 million live births. JAMA Oncol. 2019;5:1150\u20138.","journal-title":"JAMA Oncol"},{"key":"2602_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1182\/blood-2013-06-509463","volume":"123","author":"TD Buitenkamp","year":"2014","unstructured":"Buitenkamp TD, Izraeli S, Zimmermann M, Forestier E, Heerema NA, van den Heuvel-Eibrink MM, et al. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood. 2014;123:70\u20137.","journal-title":"Blood"},{"key":"2602_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1200\/JCO.23.00389","volume":"42","author":"KR Rabin","year":"2024","unstructured":"Rabin KR, Devidas M, Chen Z, Ji L, Kairalla J, Hitzler JK, et al. Outcomes in children, adolescents, and young adults with down syndrome and ALL: A report from the Children\u2019s Oncology Group. J Clin Oncol J Am Soc Clin Oncol. 2024;42:218\u201327.","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"key":"2602_CR6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1001\/jamaoncol.2023.2163","volume":"9","author":"A Verma","year":"2023","unstructured":"Verma A, Lupo PJ, Shah NN, Hitzler J, Rabin KR. Management of down syndrome-associated leukemias: a review. JAMA Oncol. 2023;9:1283\u201390.","journal-title":"JAMA Oncol"},{"key":"2602_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1182\/blood-2009-07-235291","volume":"116","author":"KW Maloney","year":"2010","unstructured":"Maloney KW, Carroll WL, Carroll AJ, Devidas M, Borowitz MJ, Martin PL, et al. Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children\u2019s Oncology Group. Blood. 2010;116:1045\u201350.","journal-title":"Blood"},{"key":"2602_CR8","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/S0140-6736(08)61341-0","volume":"372","author":"D Bercovich","year":"2008","unstructured":"Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A, et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down\u2019s syndrome. Lancet Lond Engl. 2008;372:1484\u201392.","journal-title":"Lancet Lond Engl"},{"key":"2602_CR9","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","volume":"114","author":"LJ Russell","year":"2009","unstructured":"Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ, et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood. 2009;114:2688\u201398.","journal-title":"Blood"},{"key":"2602_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/ng.469","volume":"41","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Collins-Underwood JR, Phillips LAA, Loudin MG, Liu W, Zhang J, et al. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet. 2009;41:1243\u20136.","journal-title":"Nat Genet"},{"key":"2602_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1182\/blood-2009-08-235408","volume":"115","author":"L Hertzberg","year":"2010","unstructured":"Hertzberg L, Vendramini E, Ganmore I, Cazzaniga G, Schmitz M, Chalker J, et al. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood. 2010;115:1006\u201317.","journal-title":"Blood"},{"key":"2602_CR12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/blood-2023-174139","volume":"142","author":"Z Li","year":"2023","unstructured":"Li Z, Chang TC, Junco JJ, Devidas M, Li Y, Yang W, et al. Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia. Blood. 2023;142:172\u201384.","journal-title":"Blood"},{"key":"2602_CR13","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1002\/cncr.34906","volume":"129","author":"JM Schraw","year":"2023","unstructured":"Schraw JM, Sok P, Desrosiers TA, Janitz AE, Langlois PH, Canfield MA, et al. Associations between birth defects and childhood and adolescent germ cell tumors according to sex, histologic subtype, and site. Cancer. 2023;129:3300\u20138.","journal-title":"Cancer"},{"key":"2602_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30585","volume":"70","author":"EA Raetz","year":"2023","unstructured":"Raetz EA, Bhojwani D, Devidas M, Gore L, Rabin KR, Tasian SK, et al. Children\u2019s Oncology Group blueprint for research: Acute lymphoblastic leukemia. Pediatr Blood Cancer. 2023;70:e30585.","journal-title":"Pediatr Blood Cancer"},{"key":"2602_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1053\/j.semperi.2017.07.004","volume":"41","author":"RS Kirby","year":"2017","unstructured":"Kirby RS. The prevalence of selected major birth defects in the United States. Semin Perinatol. 2017;41:338\u201344.","journal-title":"Semin Perinatol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02602-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02602-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02602-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:05:00Z","timestamp":1748948700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02602-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2602"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02602-w","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study complied with the principles of the Declaration of Helsinki and was approved by the Institutional Review Boards of participating institutions. The requirement for written informed consent was waived as it involved secondary analysis of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}